[TimAlerts] $TEAR news SAN DIEGO , Jan. 25, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) announced today that it has received approval for the TearLab Osmolarity System from the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico . This approval allows TearLab to begin selling the product to aid in the diagnosis of Dry Eye Disease (DED) in Mexico .

[TimAlerts] $ACAT buy out for $18.50 per share no play

[TimAlerts] $ETRM squeeze

[TimAlerts] WATT squeezing